Clinical Significance of Salvage Esophagectomy for Patients with Esophageal Cancer and Factors of Influencing Long-term Survival

被引:15
|
作者
Sohda, Makoto [1 ]
Kumakura, Yuji [1 ]
Saito, Hideyuki [1 ]
Kuriyama, Kengo [1 ]
Yoshida, Tomonori [1 ]
Honjyo, Hiroaki [1 ]
Hara, Keigo [1 ]
Ozawa, Daigo [1 ]
Suzuki, Shigemasa [1 ]
Tanaka, Naritaka [1 ]
Sakai, Makoto [1 ]
Miyazaki, Tatsuya [1 ]
Fukuchi, Minoru [1 ]
Kuwano, Hiroyuki [1 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan
关键词
Esophageal cancer; salvage esophagectomy; long-term survival; SQUAMOUS-CELL CARCINOMA; DEFINITIVE CHEMORADIOTHERAPY; 5-FLUOROURACIL; CISPLATIN; OUTCOMES; DOCETAXEL; SURGERY; FAILURE;
D O I
10.21873/anticanres.11920
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: Definitive chemoradiotherapy (CRT) without planned surgery has been recently widely used as a therapeutic option for locally advanced esophageal cancer. Salvage esophagectomy can offer the chance of prolonged survival for patients who have locoregional failure after definitive CRT, but many clinicians oppose the use of surgery due to the associated excessive morbidity and mortality. The aim of this study was to identify patients who are good candidates for salvage surgery by investigating factors influencing long-term survival. Patients and Methods: A total of 40 patients underwent concurrent CRT or RT followed by esophagectomy for residual tumor or locoregional recurrence of esophageal squamous cell carcinoma without distant organ metastasis at the Department of General Surgical Science, Gunma University, Gunma, Japan, and were included in this study. As short-term outcomes after salvage esophagectomy, pulmonary and cardiovascular complications, anastomotic leakage, and chylothorax, and the length of postoperative stay were evaluated. Survival rates were calculated using the Kaplan-Meier method, and the Cox proportional hazards model was used for univariate and multivariate analyses of disease-specific survival. Results: Postoperative complications were noted in 20 patients (50%), and pulmonary complications were the most common (25%), followed by anastomotic leakage (20%). There was also one case of in-hospital death, caused by multiple organ failure due to chylothorax. Univariate analysis revealed that sex, clinical residual tumor, CRT response, pathological tumor depth, and pathological residual tumor were significant factors affecting disease-specific survival (p= 0.034, p= 0.009, p= 0.014, p= 0.020, and p= 0.026, respectively). Moreover, multivariate analysis demonstrated that clinical residual tumor was the only independent factor influencing disease-specific survival (p= 0.036). Thirteen patients (32.5%) died from other illnesses after salvage surgery, 53.8% patients from pneumonia. Conclusion: Based on long-term survival, recurrence rather than residual tumor after definitive CRT was a favorable indicator for salvage esophagectomy. Not only management of postoperative morbidity and curative operation but, also long-term rigorous outpatient management, including respiratory rehabilitation to reduce pneumonia, is necessary.
引用
收藏
页码:5045 / 5051
页数:7
相关论文
共 50 条
  • [21] Prognostic factors for medium- and long-term survival of esophageal cancer patients in the Netherlands
    Bus, Pauline
    Lemmens, Valery E.
    Van Oijen, Martijn G.
    Creemers, Geert-Jan
    Nieuwenhuijzen, Grard A.
    Van Baal, Jantine W.
    Siersema, Peter D.
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (05) : 465 - 471
  • [22] Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy
    Shimada, Y
    Imamura, M
    Shibagaki, I
    Tanaka, H
    Miyahara, T
    Kato, M
    Ishizaki, K
    ANNALS OF SURGERY, 1997, 226 (02) : 162 - 168
  • [23] Esophagectomy with Extended Lymphadenectomy for Submucosal Esophageal Cancer: Long-Term Outcomes and Prognostic Factors
    Tanaka, Toshiaki
    Matono, Satoru
    Nagano, Takeshi
    Shirouzu, Kazuo
    Fujita, Hiromasa
    Yamana, Hideaki
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (03) : 750 - 756
  • [24] Esophagectomy with Extended Lymphadenectomy for Submucosal Esophageal Cancer: Long-Term Outcomes and Prognostic Factors
    Toshiaki Tanaka
    Satoru Matono
    Takeshi Nagano
    Kazuo Shirouzu
    Hiromasa Fujita
    Hideaki Yamana
    Annals of Surgical Oncology, 2012, 19 : 750 - 756
  • [25] Long-Term Prognostic Factors After Minimally Invasive Esophagectomy (MIE) for Esophageal Cancer
    Huang, Y.
    Yang, P.
    Chen, K.
    Huang, P.
    Lee, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S333 - S333
  • [26] Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma
    Lew, JI
    Gooding, WE
    Ribeiro, U
    Safatle-Ribeiro, AV
    Posner, MC
    ARCHIVES OF SURGERY, 2001, 136 (07) : 737 - 742
  • [27] Long-Term Quality of Life After Esophagectomy for Esophageal Cancer
    Katz, Amit
    Nevo, Yehonatan
    Luna, Jose Luis Ramirez Garcia
    Anchouche, Sonia
    Tankel, James
    Caminsky, Natasha
    Mueller, Carmen
    Spicer, Jonathan
    Cools-Lartigue, Jonathan
    Ferri, Lorenzo
    ANNALS OF THORACIC SURGERY, 2023, 115 (01): : 200 - 208
  • [28] Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer
    Speicher, P. J.
    Wang, X.
    Englum, B. R.
    Ganapathi, A. M.
    Yerokun, B.
    Hartwig, M. G.
    D'Amico, T. A.
    Berry, M. F.
    DISEASES OF THE ESOPHAGUS, 2015, 28 (08) : 788 - 796
  • [29] Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy
    Pather, Keouna
    Mobley, Erin M.
    Guerrier, Christina
    Esma, Rhemar
    Kendall, Heather
    Awad, Ziad T.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [30] Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy
    Keouna Pather
    Erin M. Mobley
    Christina Guerrier
    Rhemar Esma
    Heather Kendall
    Ziad T. Awad
    World Journal of Surgical Oncology, 20